Paper24722151
National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer.
Patel AP and 12 others. J Thorac Oncol, 2014. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer. Papers, record 24722151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24722151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Chemoradiotherapy | Major topic |
| Lung Neoplasms | Major topic |
| Pneumonectomy | Major topic |
| Aged | |
| Antineoplastic Agents | |
| Chemoradiotherapy, Adjuvant | |
| Female | |
| Humans | |
| Length of Stay | |
| Male | |
| Middle Aged | |
| Neoadjuvant Therapy | |
| Neoplasm Staging | |
| Practice Patterns, Physicians' | |
| Radiotherapy Dosage | |
| Survival Rate | |
| Treatment Outcome | |
| United States |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K07 CA178120 | NCI NIH HHS | United States | K07CA178120 | PubMed and NIH | NIH RePORTER |
| K12 CA167540 | NCI NIH HHS | United States | K12CA167540 | PubMed and NIH | NIH RePORTER |
| K12CA167540-02 | NCI NIH HHS | United States | K12CA167540 | PubMed and NIH | NIH RePORTER |
| K07CA178120 | NCI NIH HHS | United States | K07CA178120 | PubMed and NIH | NIH RePORTER |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17599507 | Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. | J Thorac Cardiovasc Surg | 2007 | https://conductscience.org/library/papers/17599507 | PubMed |
| 2 | 18670305 | Gaps in optimal care for lung cancer. | J Thorac Oncol | 2008 | https://conductscience.org/library/papers/18670305 | PubMed |
| 3 | 23401449 | New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23401449 | PubMed |
| 4 | 17451842 | National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. | Lung Cancer | 2007 | https://conductscience.org/library/papers/17451842 | PubMed |
| 5 | 19551884 | Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. | Cancer | 2009 | https://conductscience.org/library/papers/19551884 | PubMed |
| 6 | 19632716 | Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. | Lancet | 2009 | https://conductscience.org/library/papers/19632716 | PubMed |
| 7 | 21903745 | Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. | J Natl Cancer Inst | 2011 | https://conductscience.org/library/papers/21903745 | PubMed |
| 8 | 20100967 | Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20100967 | PubMed |
| 9 | 19875976 | Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy. | J Thorac Oncol | 2009 | https://conductscience.org/library/papers/19875976 | PubMed |
| 10 | 20416887 | Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer. | J Thorac Cardiovasc Surg | 2010 | https://conductscience.org/library/papers/20416887 | PubMed |
| 11 | 15908042 | A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer. | Lung Cancer | 2005 | https://conductscience.org/library/papers/15908042 | PubMed |
| 12 | 12142202 | Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. | Eur J Cardiothorac Surg | 2002 | https://conductscience.org/library/papers/12142202 | PubMed |
| 13 | 22233799 | Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer? | Eur J Cardiothorac Surg | 2012 | https://conductscience.org/library/papers/22233799 | PubMed |
| 14 | 21620372 | Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients. | Ann Thorac Surg | 2011 | https://conductscience.org/library/papers/21620372 | PubMed |
| 15 | 18779622 | Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18779622 | PubMed |
| 16 | 17762335 | The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. | J Thorac Oncol | 2007 | https://conductscience.org/library/papers/17762335 | PubMed |
| 17 | 23393428 | Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. | PLoS Med | 2013 | https://conductscience.org/library/papers/23393428 | PubMed |
| 18 | 22982648 | Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003. | J Thorac Oncol | 2012 | https://conductscience.org/library/papers/22982648 | PubMed |
| 19 | 22386614 | Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. | Heart Lung Circ | 2012 | https://conductscience.org/library/papers/22386614 | PubMed |
| 20 | 19049763 | Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. | Ann Thorac Surg | 2008 | https://conductscience.org/library/papers/19049763 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36997606 | Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan. | Sci Rep | 2023 | https://conductscience.org/library/papers/36997606 | PubMed |
| 36172417 | Surgical decision-making in advanced-stage non-small cell lung cancer is influenced by more than just guidelines. | JTCVS Open | 2022 | https://conductscience.org/library/papers/36172417 | PubMed |
| 36004217 | Select octogenarians with stage IIIa non-small cell lung cancer can benefit from trimodality therapy. | JTCVS Open | 2022 | https://conductscience.org/library/papers/36004217 | PubMed |
| 33777572 | Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting. | Cureus | 2021 | https://conductscience.org/library/papers/33777572 | PubMed |
| 31372055 | Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31372055 | PubMed |
| 31220530 | Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer. | Semin Thorac Cardiovasc Surg | 2020 | https://conductscience.org/library/papers/31220530 | PubMed |
| 30710323 | Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial. | Eur J Nucl Med Mol Imaging | 2019 | https://conductscience.org/library/papers/30710323 | PubMed |
| 30626407 | Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity. | J Cardiothorac Surg | 2019 | https://conductscience.org/library/papers/30626407 | PubMed |
| 30551965 | Survival benefits associated with surgery for advanced non-small cell lung cancer. | J Thorac Cardiovasc Surg | 2019 | https://conductscience.org/library/papers/30551965 | PubMed |
| 28964421 | A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients. | Ann Thorac Surg | 2017 | https://conductscience.org/library/papers/28964421 | PubMed |
| 28924214 | Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway. | Sci Rep | 2017 | https://conductscience.org/library/papers/28924214 | PubMed |
| 28532544 | [Progress of Neoadjuvant Therapy Combined with Surgery in Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2017 | https://conductscience.org/library/papers/28532544 | PubMed |
| 28203400 | Treatment of resectable stage IIIA non-small cell lung cancer. | J Thorac Dis | 2017 | https://conductscience.org/library/papers/28203400 | PubMed |
| 28110809 | Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer. | Ann Thorac Surg | 2017 | https://conductscience.org/library/papers/28110809 | PubMed |
| 27293147 | Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. | Ann Thorac Surg | 2016 | https://conductscience.org/library/papers/27293147 | PubMed |
| 26410162 | Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy. | Ann Thorac Surg | 2016 | https://conductscience.org/library/papers/26410162 | PubMed |
| 26319488 | The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis. | Ann Thorac Surg | 2015 | https://conductscience.org/library/papers/26319488 | PubMed |
| 26228601 | Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter? | Ann Thorac Surg | 2015 | https://conductscience.org/library/papers/26228601 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24722151
GET https://conductscience.org/api/papers/v1/24722151/references?page=2